Drug
Information |
Name | 2-Isoxazol-5-yl-3H-imidazo[4,5-c]quinoline |
Indication | Not Available | Experimental |
Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format
|
InChI | 1S/C13H8N4O/c1-2-4-9-8(3-1)12-10(7-14-9)16-13(17-12)11-5-6-15-18- 11/h1-7,15H/b13-11- |
InChIKey | DUIZUGINLYIMFH-QBFSEMIESA-N |
Canonical SMILES | C1=CC=C2C(=C1)C3=NC(=C4C=CNO4)N=C3C=N2 |
Isomeric SMILES | C1=CC=C2C(=C1)C3=N/C(=C\4/C=CNO4)/N=C3C=N2 |
Target | GABA receptor alpha-1 subunit |  | Inhibitor | [1] |
GABA receptor alpha-2 subunit |  | Inhibitor | [1] |
GABA receptor beta-2 subunit |  | Inhibitor | [1] |
GABA receptor gamma-2 subunit |  | Inhibitor | [1] |
Ref 1 | J Med Chem. 1996 Jul 5;39(14):2844-51.Synthesis and structure--activity relationships of fused imidazopyridines: a new series of benzodiazepine receptor ligands. To Reference |